Stanley-Laman Group, Ltd.

SEC CIK: 0001601489
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Stanley-Laman Group, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of HALO by Stanley-Laman Group, Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−63,196−100.0%	Sold out	Holders
Q1 2022	63,196	$2.52M	0.3%	−3,263−4.9%	Reduced	Holders
Q4 2021	66,459	$2.67M	0.3%	+66,459	New	Holders